Optimistic Buy Rating for Talkspace Driven by Growth Potential and Strategic Enhancements

Analyst Charles Rhyee from TD Cowen maintained a Buy rating on Talkspace and keeping the price target at $6.00.

Charles Rhyee has given his Buy rating due to a combination of factors that suggest a promising outlook for Talkspace. Despite the second quarter’s adjusted EBITDA falling short of consensus expectations, Rhyee points to several positive trends that indicate potential growth in the latter half of 2025 and into 2026. These include a notable quarter-over-quarter increase in unique paying members and an expansion in covered lives, which now includes 16 million new eligible lives from Blue Cross Blue Shield in Texas, Illinois, and Idaho.
Moreover, Talkspace has shown improvements in customer acquisition costs, attributed to long-term funnel enhancements rather than increased marketing expenses. The company’s integration into payor directories has enhanced the patient onboarding experience, which is expected to drive further conversion. Additionally, management’s decision to maintain flexibility in their adjusted EBITDA guidance allows for increased spending on sales and marketing to support future growth. These factors collectively contribute to Rhyee’s optimistic Buy rating for Talkspace.